arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

ORAGENICS INC

OGEN
$0.49 ▼ -0.01 (-1.10%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
17 Visible periods
25 Metrics
Peer-ranked Benchmarks
Price Chart
17
Health
Poor
Bearish
auto_awesome

Analytical Summary

ORAGENICS INC faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.1M
Dividend Yield
Revenue Growth None
Op. Margin
ROIC -111.5%
FCF / Share $-4.29
Trailing P/E
Price / Book 0.3x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

17-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$37.65K
↓ -71.4%
Net Income Profit after all expenses
$-9.84M
↑ +6.9%
FCF / Share Free cash flow per share
$-4.29
↑ +89.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
7
Financial Health
7
Cash Quality
63

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 17 years · 67 quarters